2023 Q2 Form 10-K Financial Statement

#000149315223017610 Filed on May 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue
YoY Change
Cost Of Revenue $45.91K $172.1K
YoY Change 4.89% 16.89%
Gross Profit -$45.91K -$172.1K
YoY Change 4.89% 16.89%
Gross Profit Margin
Selling, General & Admin $82.70K $579.5K
YoY Change 27.68% 106.64%
% of Gross Profit
Research & Development $6.070K $84.47K
YoY Change 792.65% 0.26%
% of Gross Profit
Depreciation & Amortization $1.458K $1.450K $5.834K
YoY Change -0.14% 0.0% 0.07%
% of Gross Profit
Operating Expenses $134.7K $836.1K
YoY Change 105.8% 125.65%
Operating Profit -$134.7K -$836.1K
YoY Change 23.32% 61.48%
Interest Expense $47.01K $245.2K
YoY Change -142.7% 210.01%
% of Operating Profit
Other Income/Expense, Net $16.10K $1.402M
YoY Change -98.39% 1672.49%
Pretax Income -$118.6K $565.6K
YoY Change -114.61% -228.93%
Income Tax
% Of Pretax Income
Net Earnings -$118.6K $565.6K
YoY Change -114.61% -228.93%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 $0.04
Diluted Earnings Per Share -$0.01 $0.04
COMMON SHARES
Basic Shares Outstanding 20.17M shares 15.56M shares
Diluted Shares Outstanding 19.24M shares 15.92M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.110K $32.62K $32.62K
YoY Change -94.99% -68.25% -68.25%
Cash & Equivalents $6.109K $32.62K $32.62K
Short-Term Investments
Other Short-Term Assets $31.59K $6.540K $6.540K
YoY Change 3.17% -49.96% -49.96%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $37.70K $39.16K $39.16K
YoY Change -75.27% -66.19% -66.19%
LONG-TERM ASSETS
Property, Plant & Equipment $20.43K $21.89K $21.89K
YoY Change -22.2% -21.04% -21.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $20.43K $21.89K $21.88K
YoY Change -22.23% -21.04% -21.07%
TOTAL ASSETS
Total Short-Term Assets $37.70K $39.16K $39.16K
Total Long-Term Assets $20.43K $21.89K $21.88K
Total Assets $58.13K $61.04K $61.04K
YoY Change -67.48% -57.47% -57.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $211.6K $233.4K $233.4K
YoY Change -20.37% -51.48% -51.48%
Accrued Expenses $66.21K $51.76K $51.76K
YoY Change 27.92% -93.62% -93.62%
Deferred Revenue
YoY Change
Short-Term Debt $191.4K $145.4K $145.4K
YoY Change -32.94% -26.39% -26.39%
Long-Term Debt Due $1.690K $1.780K $1.780K
YoY Change
Total Short-Term Liabilities $575.0K $609.7K $609.7K
YoY Change -59.46% -60.44% -60.44%
LONG-TERM LIABILITIES
Long-Term Debt $30.50K $30.62K $30.62K
YoY Change -5.86% -54.42% -54.42%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $30.50K $30.62K $30.62K
YoY Change -5.87% -54.42% -54.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $575.0K $609.7K $609.7K
Total Long-Term Liabilities $30.50K $30.62K $30.62K
Total Liabilities $605.5K $640.3K $640.3K
YoY Change -58.26% -60.19% -60.19%
SHAREHOLDERS EQUITY
Retained Earnings -$57.52M -$57.40M
YoY Change -0.98%
Common Stock $57.09M $56.94M
YoY Change 0.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$547.4K -$579.3K -$579.3K
YoY Change
Total Liabilities & Shareholders Equity $58.13K $61.04K $61.04K
YoY Change -67.48% -57.47% -57.47%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$118.6K $565.6K
YoY Change -114.61% -228.93%
Depreciation, Depletion And Amortization $1.458K $1.450K $5.834K
YoY Change -0.14% 0.0% 0.07%
Cash From Operating Activities -$119.9K -$110.3K -$540.6K
YoY Change 11.14% -35.19% 5.7%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $5.000K
YoY Change
Cash From Investing Activities $0.00 $5.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $195.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $93.41K 92.24K $465.5K
YoY Change -26.45% -62.79% -23.37%
NET CHANGE
Cash From Operating Activities -$119.9K -110.3K -$540.6K
Cash From Investing Activities 0.000 $5.000K
Cash From Financing Activities $93.41K 92.24K $465.5K
Net Change In Cash -$26.51K -18.11K -$70.13K
YoY Change -238.71% -123.34% -173.03%
FREE CASH FLOW
Cash From Operating Activities -$119.9K -$110.3K -$540.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001172178
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
usd
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022 LBSR Gain On Forgiveness Of Loan
GainOnForgivenessOfLoan
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 LBSR Gain On Disposal Of Fixed Asset
GainOnDisposalOfFixedAsset
usd
CY2023 LBSR Stock Issued During Period Value Cashless Exercise Of Options
StockIssuedDuringPeriodValueCashlessExerciseOfOptions
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022 LBSR Gain On Forgiveness Of Loan
GainOnForgivenessOfLoan
usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CY2022 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 LBSR Prepaid Insurance Financed With Note Payable
PrepaidInsuranceFinancedWithNotePayable
usd
CY2022 LBSR Shares Issued For Settlement Of Liability
SharesIssuedForSettlementOfLiability
usd
CY2022 us-gaap Loss On Derivative Instruments Pretax
LossOnDerivativeInstrumentsPretax
usd
CY2022 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
usd
CY2022 LBSR Shares Of Convertible Debt
SharesOfConvertibleDebt
shares
CY2023Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2022Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2022Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
usd
CY2021Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
usd
CY2022Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
usd
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-50071
CY2023 dei Entity Registrant Name
EntityRegistrantName
LIBERTY STAR URANIUM & METALS CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0175540
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
2 East Congress Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 900
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Tucson
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85701
CY2023 dei City Area Code
CityAreaCode
520
CY2023 dei Local Phone Number
LocalPhoneNumber
425-1433
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21888 usd
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Public Float
EntityPublicFloat
12712191 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20172429 shares
CY2023 dei Auditor Firm
AuditorFirmId
76
CY2023 dei Auditor Name
AuditorName
Turner, Stone & Company, L.L.P
CY2023 dei Auditor Location
AuditorLocation
Dallas, Texas
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32616 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102741 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6540 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13066 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
39156 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
115807 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88742 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
836071 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27722 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
21888 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
27722 usd
CY2023Q1 us-gaap Assets
Assets
61044 usd
CY2022Q1 us-gaap Assets
Assets
143529 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
233397 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
486629 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2754 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
33760 usd
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
20178 usd
CY2023Q1 LBSR Convertible Note Payable Current
ConvertibleNotePayableCurrent
92624 usd
CY2022Q1 LBSR Convertible Note Payable Current
ConvertibleNotePayableCurrent
181122 usd
CY2023Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
1782 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
172393 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
609712 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1543702 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
30618 usd
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
64897 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
30618 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
64897 usd
CY2023Q1 us-gaap Liabilities
Liabilities
640330 usd
CY2022Q1 us-gaap Liabilities
Liabilities
1608599 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
74800000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
74800000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18671159 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18671159 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13458752 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13458752 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
186 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
135 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
186 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
135 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56941222 usd
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56503616 usd
CY2023Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
117468 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57403227 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57968822 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-579286 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1465070 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61044 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
143529 usd
CY2023 us-gaap Exploration Expense
ExplorationExpense
84472 usd
CY2022 us-gaap Exploration Expense
ExplorationExpense
84252 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
172123 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
147249 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
173636 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
197517 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
405840 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
517760 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-836071 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-517760 usd
CY2023 us-gaap Interest Expense
InterestExpense
245156 usd
CY2022 us-gaap Interest Expense
InterestExpense
147199 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1065 usd
CY2023 LBSR Gain On Forgiveness Of Loan
GainOnForgivenessOfLoan
32851 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
998284 usd
CY2023 LBSR Gain On Disposal Of Fixed Asset
GainOnDisposalOfFixedAsset
5000 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
609622 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
226278 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1401666 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
79079 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
565595 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-438681 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15558746 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10647908 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15916651 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10647908 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-2011477 usd
CY2022 LBSR Stock Issued During Period Common Stock And Warrants In Private Placement Net
StockIssuedDuringPeriodCommonStockAndWarrantsInPrivatePlacementNet
157100 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
132374 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
217540 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
626187 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-734070 usd
CY2022 LBSR Resolution Of Derivative Liabilities Due To Debt Conversions And Untainted Warrants
ResolutionOfDerivativeLiabilitiesDueToDebtConversionsAndUntaintedWarrants
585957 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-438681 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1465070 usd
CY2023 LBSR Stock Issued During Period Common Stock And Warrants In Private Placement Net
StockIssuedDuringPeriodCommonStockAndWarrantsInPrivatePlacementNet
5000 usd
CY2023 LBSR Issuance Of Common Stock And Warrants In Private Placement And Warrant Exercises Related Party
IssuanceOfCommonStockAndWarrantsInPrivatePlacementAndWarrantExercisesRelatedParty
3000 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
187030 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
374640 usd
CY2023 LBSR Shares Issued To Settle Liabilities Related Party
SharesIssuedToSettleLiabilitiesRelatedParty
18650 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
276692 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
44707 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-734294 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
144764 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
565595 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-579286 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
565595 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-438681 usd
CY2023 us-gaap Depreciation
Depreciation
5834 usd
CY2022 us-gaap Depreciation
Depreciation
5834 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
276692 usd
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
229698 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
97429 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
609622 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
226278 usd
CY2023 LBSR Gain On Forgiveness Of Loan
GainOnForgivenessOfLoan
32851 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
998284 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-31276 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8251 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3940 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7177 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
10716 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-540602 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-511448 usd
CY2023 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
5000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24550 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18996 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
32497 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
50000 usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
21996 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
236889 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
285500 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195030 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
287374 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2100 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
465477 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
607471 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70125 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
96023 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
102741 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6718 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32616 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
102741 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
942 usd
CY2023 LBSR Resolution Of Derivative Liabilities Due To Debt Conversions And Untainted Warrants
ResolutionOfDerivativeLiabilitiesDueToDebtConversionsAndUntaintedWarrants
144764 usd
CY2022 LBSR Resolution Of Derivative Liabilities Due To Debt Conversions And Untainted Warrants
ResolutionOfDerivativeLiabilitiesDueToDebtConversionsAndUntaintedWarrants
585957 usd
CY2023 LBSR Reclass Of Apic To Derivative Liabilities For Tainted Warrants
ReclassOfApicToDerivativeLiabilitiesForTaintedWarrants
734294 usd
CY2022 LBSR Reclass Of Apic To Derivative Liabilities For Tainted Warrants
ReclassOfApicToDerivativeLiabilitiesForTaintedWarrants
734070 usd
CY2023 LBSR Debt Discounts Due To Derivative Liabilities
DebtDiscountsDueToDerivativeLiabilities
192485 usd
CY2022 LBSR Debt Discounts Due To Derivative Liabilities
DebtDiscountsDueToDerivativeLiabilities
78165 usd
CY2023 us-gaap Stock Issued1
StockIssued1
374640 usd
CY2022 us-gaap Stock Issued1
StockIssued1
217540 usd
CY2023 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
18096 usd
CY2022 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
54960 usd
CY2023 LBSR Prepaid Insurance Financed With Note Payable
PrepaidInsuranceFinancedWithNotePayable
24750 usd
CY2023 LBSR Shares Issued For Settlement Of Liability
SharesIssuedForSettlementOfLiability
18650 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-438681 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zeC4QmL1uv4i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zRYLKPjQlkT7">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The valuation of stock-based compensation, classification and valuation of common stock purchase warrants, classification and value of embedded conversion options, value of beneficial conversion features, valuation allowance on deferred tax assets, the determination of useful lives and recoverability of depreciable assets, accruals, and contingencies are significant estimates made by management. It is at least reasonably possible that a change in these estimates may occur in the near term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Cash
Cash
0 usd
CY2022Q1 us-gaap Cash
Cash
0 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15558746 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10647908 shares
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
500 usd
CY2023 LBSR Shares Of Convertible Debt
SharesOfConvertibleDebt
357905 shares
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15916651 shares
CY2023 LBSR Shares Of Convertible Debt
SharesOfConvertibleDebt
357905 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
565595 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-438681 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15558746 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10647908 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023 us-gaap Net Income Loss
NetIncomeLoss
565595 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-438681 usd
CY2023 us-gaap Loss On Derivative Instruments Pretax
LossOnDerivativeInstrumentsPretax
4440 usd
CY2023 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
229968 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
799333 usd
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10647908 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zsBzZIFOyUPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zO8sRQOWmJ5c">Reclassification</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to our prior year’s financial statements to conform to our current year presentation. These reclassifications had no effect on our previously reported results of operations or accumulated deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
129152 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
435228 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
107264 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
407506 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21888 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27722 usd
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
265403 usd
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
40673 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000 usd
CY2023 us-gaap Depreciation
Depreciation
5834 usd
CY2022 us-gaap Depreciation
Depreciation
5834 usd
CY2023Q1 us-gaap Convertible Debt
ConvertibleDebt
126384 usd
CY2022Q1 us-gaap Convertible Debt
ConvertibleDebt
201300 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
33760 usd
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
20178 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
92624 usd
CY2022Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
181122 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2754 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
609622 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
226278 usd
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
609622 usd
CY2022 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
226278 usd
CY2023 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
-144764 usd
CY2022 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Settlements
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
-585957 usd
CY2023 LBSR Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Additions Recognized As Debt Discount
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAdditionsRecognizedAsDebtDiscount
192485 usd
CY2022 LBSR Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Additions Recognized As Debt Discount
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAdditionsRecognizedAsDebtDiscount
78165 usd
CY2023 LBSR Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Additions Due To Tainted Warrants
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAdditionsDueToTaintedWarrants
734294 usd
CY2022 LBSR Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Additions Due To Tainted Warrants
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationAdditionsDueToTaintedWarrants
734070 usd
CY2023Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
172393 usd
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-609622 usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-226278 usd
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Class A Common Stock has super majority voting rights with the holder of each outstanding share of Class A Common Stock being entitled to 200 votes per share on all such matters, including, but not limited to, election of the Board of Directors.
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
74800000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
146000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.019
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M9D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
750 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.500
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
145250 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.965
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M24D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
987760 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.18
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
145250 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.97
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
674000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.15
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
313760 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.53
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P13Y8M8D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
313760 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.53
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P13Y8M8D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.119
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.385
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2256070 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1748538 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y5M19D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.82
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
0 usd
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
10012 usd
CY2022Q2 LBSR Warrants Extend Of Expiration Description
WarrantsExtendOfExpirationDescription
the Company extended all warrants issued by the Company which expired or will expire during the year 2022. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, fully considering the reverse split effective on February 25, 2021, which applied equivalently to price and number of shares for all warrants.
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6712000 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6872000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6712000 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6872000 usd
CY2023Q1 LBSR Decrease In Net Operating Loss Carryforwards
DecreaseInNetOperatingLossCarryforwards
160000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
32000000 usd
CY2023 LBSR Operating Loss Carryforwards Expiration Description
OperatingLossCarryforwardsExpirationDescription
beginning in 2026 through 2038
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Internal Revenue Code Section 382 limits the ability to utilize net operating losses if a 50% change in ownership occurs over a three-year period.
CY2023Q1 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
66205 usd
CY2022Q1 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
65807 usd
CY2023 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
50000 usd
CY2023Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.10 pure
CY2023 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-01-31
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9167 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
75000 shares
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.15
CY2022Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
6302 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.15
CY2022Q3 LBSR Fair Value Of Stock Options
FairValueOfStockOptions
104226 usd
CY2022Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0315 pure
CY2023Q1 LBSR Subscription Receivables
SubscriptionReceivables
-101100 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
708 usd
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.269
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.377
CY2023 us-gaap Payments For Rent
PaymentsForRent
165 usd
CY2023 LBSR Lease Due Date
LeaseDueDate
2023-09-01
CY2023Q1 LBSR Written Off Liabilities
WrittenOffLiabilities
1072667 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
29677 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
44707 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
998284 usd

Files In Submission

Name View Source Status
0001493152-23-017610-index-headers.html Edgar Link pending
0001493152-23-017610-index.html Edgar Link pending
0001493152-23-017610.txt Edgar Link pending
0001493152-23-017610-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_000003.jpg Edgar Link pending
form10-k_000004.jpg Edgar Link pending
form10-k_001.jpg Edgar Link pending
lbsr-20230131.xsd Edgar Link pending
form10-k_htm.xml Edgar Link completed
logo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
lbsr-20230131_def.xml Edgar Link unprocessable
lbsr-20230131_lab.xml Edgar Link unprocessable
lbsr-20230131_pre.xml Edgar Link unprocessable
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lbsr-20230131_cal.xml Edgar Link unprocessable